Categories: Medical News

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Spread the love

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments. …read more    

AHIT

Share
Published by
AHIT

Recent Posts

South Africa steps up cancer data gathering

By: Elna Schütz [JOHANNESBURG] South Africa has begun collecting data on cancer directly from patients…

2 months ago

Kenya’s healthcare system needs immersive technologies

Kenya's healthcare system faces numerous challenges, including limited access to specialists, uneven distribution of resources…

3 months ago

Adoption of Technology to Address Africa’s Healthcare Challenges

Technological transformation has   been  advocated for a sweeping technological transformation to confront the critical healthcare…

3 months ago

AI a ‘potent remedy’ for Africa’s health challenges

By: Jackie Opara [LAGOS] Artificial Intelligence (AI) could emerge as a potent remedy for long-standing…

3 months ago

HealthTech Hub Africa receives support to fast-track health tech innovation.s across the continent.

The African Development Bank Group has entered into an agreement with the HealthTech Hub Africa…

3 months ago

Tanzania: Dawa Mkononi secures funding to enhance healthcare access

Dawa Mkononi, a B2B pharmaceutical firm based in Tanzania, focused on using innovation to improve…

3 months ago